Trial Profile
Phase I Clinical trial of the safe use of perispinal Etanercept (Tumour Necrosis Factor-Alpha blocker) in Australian patients with progressive dementia
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Therapeutic Use
- 28 Aug 2012 New trial record